Literature DB >> 10867137

Disruption of the IFN-gamma cytokine network in chronic lymphocytic leukemia contributes to resistance of leukemic B cells to apoptosis.

M Zaki1, R Douglas, N Patten, M Bachinsky, R Lamb, P Nowell, J Moore.   

Abstract

Recent evidence indicates that the slowly expanding population of CD5+ B cells that characterizes chronic lymphocytic leukemia (CLL) results primarily from defects in responses to cytokines that regulate apoptosis (e.g. I1-4, TGF-beta, IFN-alpha, IFN-gamma). We have now demonstrated not only that the enhanced anti-apoptotic effect of IFN-gamma on these neoplastic B cells is apparently mediated through increased levels of IFN-gamma receptors but also that there are increased numbers of IFN-gamma-expressing CD4 and CD8 T cells in these patients. This is the strongest evidence to date that multiple alterations in the IFN-gamma cytokine network contribute to the pathogenesis of CLL.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867137     DOI: 10.1016/s0145-2126(00)00022-9

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells.

Authors:  R Thijssen; J Ter Burg; G G W van Bochove; M F M de Rooij; A Kuil; M H Jansen; T W Kuijpers; J W Baars; A Virone-Oddos; M Spaargaren; C Egile; M H J van Oers; E Eldering; M J Kersten; A P Kater
Journal:  Leukemia       Date:  2015-09-04       Impact factor: 11.528

2.  NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors.

Authors:  Alexander W MacFarlane; Mowafaq Jillab; Mitchell R Smith; R Katherine Alpaugh; Marion E Cole; Samuel Litwin; Michael M Millenson; Tahseen Al-Saleem; Adam D Cohen; Kerry S Campbell
Journal:  Oncoimmunology       Date:  2017-05-19       Impact factor: 8.110

3.  Death-associated Protein Kinase-1 Expression and Autophagy in Chronic Lymphocytic Leukemia Are Dependent on Activating Transcription Factor-6 and CCAAT/Enhancer-binding Protein-β.

Authors:  Padmaja Gade; Amy S Kimball; Angela C DiNardo; Priyamvada Gangwal; Douglas D Ross; H Scott Boswell; Susan K Keay; Dhananjaya V Kalvakolanu
Journal:  J Biol Chem       Date:  2016-09-02       Impact factor: 5.157

4.  Potential role of serum level of soluble CD44 and IFN-γ in B-cell chronic lymphocytic leukemia.

Authors:  Nervana Samy; M D Abd El-Maksoud; T E Mousa; Hatem A El-Mezayen; Mohamed Shaalan
Journal:  Med Oncol       Date:  2010-08-31       Impact factor: 3.064

5.  IFN gamma gene polymorphism may contribute to the susceptibility to CLL.

Authors:  Iwona Urbanowicz; Grzegorz Mazur; Jolanta Stacherzak-Pawlik; Katarzyna Bogunia-Kubik; Tomasz Wróbel; Mieczysław Woźniak; Kazimierz Kuliczkowski
Journal:  Pathol Oncol Res       Date:  2009-09-15       Impact factor: 3.201

6.  TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.

Authors:  Kemal Catakovic; Franz Josef Gassner; Christoph Ratswohl; Nadja Zaborsky; Stefan Rebhandl; Maria Schubert; Markus Steiner; Julia Christine Gutjahr; Lisa Pleyer; Alexander Egle; Tanja Nicole Hartmann; Richard Greil; Roland Geisberger
Journal:  Oncoimmunology       Date:  2017-09-21       Impact factor: 8.110

Review 7.  The Newly Identified T Helper 22 Cells Lodge in Leukemia.

Authors:  Gholamreza Azizi; Mohsen Rastegar Pouyani; Shadi Sadat Navabi; Reza Yazdani; Fatemeh Kiaee; Abbas Mirshafiey
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-07-01

8.  Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL.

Authors:  Gerardo Ferrer; Byeongho Jung; Pui Yan Chiu; Rukhsana Aslam; Florencia Palacios; Andrea Nicola Mazzarello; Stefano Vergani; Davide Bagnara; Shih-Shih Chen; Sophia Yancopoulos; Aliki Xochelli; Xiao-Jie Yan; Jan A Burger; Jacqueline C Barrientos; Jonathan E Kolitz; Steven L Allen; Kostas Stamatopoulos; Kanti R Rai; Barbara Sherry; Nicholas Chiorazzi
Journal:  Leukemia       Date:  2021-05-02       Impact factor: 12.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.